During the 12-month contraception study period
(7/1/98–6/30/99), we recorded the use of oral contraceptive
pills (OCP), medroxyprogesterone injection
(Depo-Provera), levonorgesterol implants (Norplant),
and intrauterine devices (IUD) based upon pharmacy,
medical, or institutional claims